Document is current
Any future updates will be listed below
-
Authors
Frade, Marco Andrey Cipriani https://orcid.org/0000-0003-2700-5971
Albertino, Gustavo Sartori https://orcid.org/0000-0003-0728-7828
Lima, Filipe Rocha https://orcid.org/0000-0001-7629-4963
de Paula, Natália Aparecida https://orcid.org/0000-0002-3744-8947
Cinto, Fabiana Aparecida Correa
Perecin, Fernanda Cruz
Westin, Andrezza
Junior, Wilson Marques
Lugão, Helena Barbosa https://orcid.org/0000-0003-1623-7443
-
Funding
Funding for this research was provided by:
Coordination of Higher Education Personnel Improvement
Conselho Nacional de Desenvolvimento Científico e Tecnológico (749145/2010)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (767202/2011)
Conselho Nacional de Desenvolvimento Científico e Tecnológico (423635/2018\u20132)
Fundação Oswaldo Cruz (25380.102201/2019)
Fundação Oswaldo Cruz (PRES-009-FIO-20)
Fundação de Apoio ao Ensino, Pesquisa e Assistência
State of Sao Paulo Research Foundation (2023/00589-6)
State of Sao Paulo Research Foundation (2021/13429-1)
State of Sao Paulo Research Foundation (2023/00636\u20134)
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: RIMOXCLAMIN: New therapeutic regimen for Hansen’s Disease cure based on effective sensitivity recovery
Journal Title: The Brazilian Journal of Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2025.104539
Content Type: article
Copyright: © 2025 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.
